Name | Title | Contact Details |
---|---|---|
Jordan Clothier |
Senior Assistant General Counsel | Profile |
Catharine Fortney |
Chief Compliance and Audit Officer | Profile |
Shachi Mankodi |
Senior Assistant General Counsel | Profile |
Northfield Hospital & Clinics is an independent, integrated health care organization providing a wide range of healthcare services to patients throughout the southern metro region. Northfield Hospital & Clinics’ regional approach is designed to extend primary care services throughout the area and provide the patient base necessary to develop important specialty practices, such as cardiology and oncology, and make them more accessible to area residents. Our individual clinics include the primary and specialty care FamilyHealth Clinics located in Lonsdale, Northfield, Farmington, Elko New Market and Lakeville. The Northfield Hospital & Clinics network also features specialty clinics, including Women’s Health Center, Orthopaedic & Fracture Clinic, and Northfield Eye Physicians & Surgeons. Become an exceptional healthcare system and the provider of choice in the region.Northfield Hospital & Clinics provides a wide spectrum of medical services to residents of Rice, Dakota, Scott and Goodhue counties. Combining advanced technology with personalized, patient-centered care, we strive to create a healing environment where patients feel safe, secure and supported.
Lighthouse Rehabilitation Ctr is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Caro, MI. To find more information about Lighthouse Rehabilitation Ctr, please visit www.lighthouserehab.com
Metabolon, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Durham, NC. To find more information about Metabolon, Inc., please visit www.metabolon.com
Discovery Laboratories, Inc. is a specialty biotechnology company focused on advancing a new standard in respiratory critical care. Discovery Labs` technology platform includes its novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant, and its proprietary drug delivery technologies being developed to enable efficient delivery of aerosolized KL4 surfactant and other inhaled therapies. Discovery Labs` strategy is initially focused on neonatology and improving the management of respiratory distress syndrome (RDS) in premature infants. Discovery Labs believes that its RDS product portfolio has the potential to become the new standard of care for RDS and, over time, enable the treatment of a significantly greater number of premature infants who could benefit from surfactant therapy that are currently not being treated. In many pulmonary diseases, including RDS, acute lung injury (ALI), and other respiratory conditions, surfactant is either deficient or may fail to function properly. Our precision-engineered, peptide-containing KL4 surfactant has been designed to mimic the essential function of human pulmonary surfactant and may have the potential to address conditions such as these. We are developing our proprietary delivery technologies to one day enable efficient, targeted upper-respiratory or alveolar delivery of our KL4 surfactant in aerosolized form to allow for a gentler, less invasive delivery approach. These same delivery systems may also potentially be used to deliver a variety of additional aerosolized medicines safely and in a simplified way compared with the current standard of care.
Sunquest Information Systems, Inc. provides healthcare information systems to large and mid-sized hospitals, clinics and other facilities, including integrated delivery networks comprised of multi-entity, multi-site healthcare organizations.